stem cell therapy (Tianjin Medical University Cancer Institute and Hospital)

N/A

Report date: 2025/03/20 09:19:28

Base Information

Drug Namestem cell therapy (Tianjin Medical University Cancer Institute and Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Peripheral blood stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Medical University Cancer Institute And Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Medical University Cancer Institute And Hospital
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A